{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:06:27Z","timestamp":1789427187489,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T00:00:00Z","timestamp":1789430400000},"content-version":"vor","delay-in-days":80,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"DOI":"10.1007\/s00423-026-04118-y","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T10:25:47Z","timestamp":1782555947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative analysis of survival outcomes and prognostic factors between intrahepatic and extrahepatic cholangiocarcinoma after surgical resection: a propensity score-matched study based on the SEER database"],"prefix":"10.1007","volume":"411","author":[{"given":"Jize","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"4118_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2024.104003","volume":"10","author":"A Vogel","year":"2025","unstructured":"Vogel A, Ducreux M (2025) ESMO clinical practice guideline interim update on the management of biliary tract cancer. ESMO Open 10:104003. https:\/\/doi.org\/10.1016\/j.esmoop.2024.104003","journal-title":"ESMO Open"},{"key":"4118_CR2","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73:17\u201348. https:\/\/doi.org\/10.3322\/caac.21763","journal-title":"CA Cancer J Clin"},{"key":"4118_CR3","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","volume":"17","author":"JM Banales","year":"2020","unstructured":"Banales JM, Marin JJG, Lamarca A et al (2020) Cholangiocarcinoma 2020: the next horizon in mechanisms and management. Nat Rev Gastroenterol Hepatol 17:557\u2013588. https:\/\/doi.org\/10.1038\/s41575-020-0310-z","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4118_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/diseases020031","author":"A Bangolo","year":"2025","unstructured":"Bangolo A, Nagesh VK, Tran HH et al (2025) Age and Tumor Stage Interplay in Intrahepatic Cholangiocarcinoma: Prognostic Factors, Mortality Trends, and Therapeutic Implications from a SEER-Based Analysis. Diseases. https:\/\/doi.org\/10.3390\/diseases13020031","journal-title":"Diseases"},{"key":"4118_CR5","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ajpath.2024.08.014","volume":"195","author":"RV Guest","year":"2025","unstructured":"Guest RV, Goeppert B, Nault JC, Sia D (2025) Morphomolecular pathology and genomic insights into the cells of origin of cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma. Am J Pathol 195:345\u2013361. https:\/\/doi.org\/10.1016\/j.ajpath.2024.08.014","journal-title":"Am J Pathol"},{"key":"4118_CR6","doi-asserted-by":"publisher","first-page":"359","DOI":"10.5858\/arpa.2022-0537-RA","volume":"148","author":"P Gopal","year":"2024","unstructured":"Gopal P, Robert ME, Zhang X (2024) Cholangiocarcinoma: pathologic and molecular classification in the era of precision medicine. Arch Pathol Lab Med 148:359\u2013370. https:\/\/doi.org\/10.5858\/arpa.2022-0537-RA","journal-title":"Arch Pathol Lab Med"},{"key":"4118_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.molmed.2025.01.008","volume":"31","author":"A De Santis","year":"2025","unstructured":"De Santis A, Zhu L, Tao J, Rei\u00dffelder C, Sch\u00f6lch S (2025) Molecular subtypes of intrahepatic cholangiocarcinoma. Trends Mol Med 31:755\u2013769. https:\/\/doi.org\/10.1016\/j.molmed.2025.01.008","journal-title":"Trends Mol Med"},{"key":"4118_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.jhep.2019.10.009","volume":"72","author":"RK Kelley","year":"2020","unstructured":"Kelley RK, Bridgewater J, Gores GJ, Zhu AX (2020) Systemic therapies for intrahepatic cholangiocarcinoma. J Hepatol 72:353\u2013363. https:\/\/doi.org\/10.1016\/j.jhep.2019.10.009","journal-title":"J Hepatol"},{"key":"4118_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2024.101170","volume":"50","author":"L Rimassa","year":"2025","unstructured":"Rimassa L, Lamarca A, O\u2019Kane GM et al (2025) New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe. Lancet Reg Health Eur 50:101170. https:\/\/doi.org\/10.1016\/j.lanepe.2024.101170","journal-title":"Lancet Reg Health Eur"},{"key":"4118_CR10","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.annonc.2022.10.506","volume":"34","author":"A Vogel","year":"2023","unstructured":"Vogel A, Bridgewater J, Edeline J et al (2023) Biliary tract cancer: ESMO clinical practice guideline for diagnosis, treatment and follow-up. Ann Oncol 34:127\u2013140. https:\/\/doi.org\/10.1016\/j.annonc.2022.10.506","journal-title":"Ann Oncol"},{"key":"4118_CR11","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jhep.2019.11.020","volume":"72","author":"V Mazzaferro","year":"2020","unstructured":"Mazzaferro V, Gorgen A, Roayaie S, Droz Dit Busset M, Sapisochin G (2020) Liver resection and transplantation for intrahepatic cholangiocarcinoma. J Hepatol 72:364\u2013377. https:\/\/doi.org\/10.1016\/j.jhep.2019.11.020","journal-title":"J Hepatol"},{"key":"4118_CR12","doi-asserted-by":"publisher","unstructured":"(2023) EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma. J Hepatol 79:181\u2013208. https:\/\/doi.org\/10.1016\/j.jhep.2023.03.010","DOI":"10.1016\/j.jhep.2023.03.010"},{"key":"4118_CR13","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1080\/14737140.2022.1999809","volume":"22","author":"DB Hewitt","year":"2022","unstructured":"Hewitt DB, Brown ZJ, Pawlik TM (2022) Surgical management of intrahepatic cholangiocarcinoma. Expert Rev Anticancer Ther 22:27\u201338. https:\/\/doi.org\/10.1080\/14737140.2022.1999809","journal-title":"Expert Rev Anticancer Ther"},{"key":"4118_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.108248","volume":"51","author":"AK Malik","year":"2025","unstructured":"Malik AK, Davidson BR, Manas DM (2025) Surgical management, including the role of transplantation, for intrahepatic and peri-hilar cholangiocarcinoma. Eur J Surg Oncol 51:108248. https:\/\/doi.org\/10.1016\/j.ejso.2024.108248","journal-title":"Eur J Surg Oncol"},{"key":"4118_CR15","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1159\/000543439","volume":"43","author":"SY Zhong","year":"2025","unstructured":"Zhong SY, Gao SY, Jiang Y et al (2025) Association between the achievement of textbook outcomes in liver surgery and overall survival in perihilar cholangiocarcinoma patients following major hepatectomy: a multicenter study. Dig Dis 43:179\u2013189. https:\/\/doi.org\/10.1159\/000543439","journal-title":"Dig Dis"},{"key":"4118_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-049789","volume":"12","author":"WW Liu","year":"2022","unstructured":"Liu WW, Tu JF, Ying XH, Chen ZJ, Wang YB (2022) Postoperative survival of extrahepatic and intrahepatic cholangiocarcinoma after surgery: a population-based cohort. BMJ Open 12:e049789. https:\/\/doi.org\/10.1136\/bmjopen-2021-049789","journal-title":"BMJ Open"},{"key":"4118_CR17","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1093\/jnci\/djad046","volume":"115","author":"K Spencer","year":"2023","unstructured":"Spencer K, Pappas L, Baiev I et al (2023) Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma. J Natl Cancer Inst 115:870\u2013880. https:\/\/doi.org\/10.1093\/jnci\/djad046","journal-title":"J Natl Cancer Inst"},{"key":"4118_CR18","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s40001-025-02654-9","volume":"30","author":"Y Yang","year":"2025","unstructured":"Yang Y, Sheng J, Aibaidula A et al (2025) Prognostic impact of lymph node and surgical margin in patients with perihilar cholangiocarcinoma. Eur J Med Res 30:374. https:\/\/doi.org\/10.1186\/s40001-025-02654-9","journal-title":"Eur J Med Res"},{"key":"4118_CR19","doi-asserted-by":"publisher","first-page":"5849","DOI":"10.3390\/curroncol30060438","volume":"30","author":"NA Rogacka","year":"2023","unstructured":"Rogacka NA, Benk\u00f6 T, Saner FH et al (2023) Lymph Node Staging in Perihilar Cholangiocarcinoma: The Key to the Big Picture. Curr Oncol 30:5849\u20135862. https:\/\/doi.org\/10.3390\/curroncol30060438","journal-title":"Curr Oncol"},{"key":"4118_CR20","doi-asserted-by":"publisher","first-page":"965401","DOI":"10.3389\/fsurg.2022.965401","volume":"9","author":"Q Zhang","year":"2022","unstructured":"Zhang Q, Liu Z, Liu S et al (2022) A novel nomogram for adult primary perihilar cholangiocarcinoma and considerations concerning lymph node dissection. Front Surg 9:965401. https:\/\/doi.org\/10.3389\/fsurg.2022.965401","journal-title":"Front Surg"},{"key":"4118_CR21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.17235\/reed.2025.11051\/2024","volume":"117","author":"J Garc\u00eda-Cano","year":"2025","unstructured":"Garc\u00eda-Cano J, Domper F (2025) Diagnosing hilar cholangiocarcinoma: ERCP with cholangioscopy. Rev Esp Enferm Dig 117:125\u2013128. https:\/\/doi.org\/10.17235\/reed.2025.11051\/2024","journal-title":"Rev Esp Enferm Dig"},{"key":"4118_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13020233","author":"DW Shin","year":"2023","unstructured":"Shin DW, Moon SH, Kim JH (2023) Diagnosis of cholangiocarcinoma. Diagnostics (Basel). https:\/\/doi.org\/10.3390\/diagnostics13020233","journal-title":"Diagnostics (Basel)"},{"key":"4118_CR23","doi-asserted-by":"publisher","first-page":"4888","DOI":"10.1245\/s10434-023-13498-0","volume":"30","author":"D Aliseda","year":"2023","unstructured":"Aliseda D, Sapisochin G, Mart\u00ed-Cruchaga P et al (2023) Association of Laparoscopic Surgery with Improved Perioperative and Survival Outcomes in Patients with Resectable Intrahepatic Cholangiocarcinoma: A Systematic Review and Meta-Analysis from Propensity-Score Matched Studies. Ann Surg Oncol 30:4888\u20134901. https:\/\/doi.org\/10.1245\/s10434-023-13498-0","journal-title":"Ann Surg Oncol"},{"key":"4118_CR24","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1159\/000541646","volume":"14","author":"C Sposito","year":"2025","unstructured":"Sposito C, Cucchetti A, Ratti F et al (2025) Probability of Lymph Node Metastases in Patients Undergoing Adequate Lymphadenectomy during Surgery for Intrahepatic Cholangiocarcinoma: A Retrospective Multicenter Study. Liver Cancer 14:260\u2013270. https:\/\/doi.org\/10.1159\/000541646","journal-title":"Liver Cancer"},{"key":"4118_CR25","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1186\/s12957-022-02870-1","volume":"20","author":"J Wang","year":"2022","unstructured":"Wang J, Wang W, Chen X et al (2022) Laparoscopic versus open hepatectomy for intrahepatic cholangiocarcinoma in patients aged 60 and older: a retrospective cohort study. World J Surg Oncol 20:396. https:\/\/doi.org\/10.1186\/s12957-022-02870-1","journal-title":"World J Surg Oncol"},{"key":"4118_CR26","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4174\/astr.2024.107.1.16","volume":"107","author":"X Dong","year":"2024","unstructured":"Dong X, Zhang P, Ye C, Li L (2024) A personalized prognostic model for long-term survival in patients with intrahepatic cholangiocarcinoma: a retrospective cohort study. Ann Surg Treat Res 107:16\u201326. https:\/\/doi.org\/10.4174\/astr.2024.107.1.16","journal-title":"Ann Surg Treat Res"},{"key":"4118_CR27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1007\/s00423-023-03023-y","volume":"408","author":"N Nevermann","year":"2023","unstructured":"Nevermann N, Bode J, Vischer M et al (2023) A surgical strategy for intrahepatic cholangiocarcinoma - the hilar first concept. Langenbecks Arch Surg 408:296. https:\/\/doi.org\/10.1007\/s00423-023-03023-y","journal-title":"Langenbecks Arch Surg"},{"key":"4118_CR28","doi-asserted-by":"publisher","unstructured":"Baumgartner R, Gilg S, Bj\u00f6rnsson B et al (2022) Impact of post-hepatectomy liver failure on morbidity and short- and long-term survival after major hepatectomy. BJS Open 6. https:\/\/doi.org\/10.1093\/bjsopen\/zrac097","DOI":"10.1093\/bjsopen\/zrac097"},{"key":"4118_CR29","doi-asserted-by":"publisher","DOI":"10.1007\/s44197-025-00371-4","volume":"15","author":"S Temraz","year":"2025","unstructured":"Temraz S, Charafeddine M, Khalifeh MJ, Shamseddine A (2025) Pre-operative markers of post-operative complications in pancreatic cancer patients: a single-center study. J Epidemiol Glob Health 15:28. https:\/\/doi.org\/10.1007\/s44197-025-00371-4","journal-title":"J Epidemiol Glob Health"},{"key":"4118_CR30","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.pan.2023.11.016","volume":"24","author":"S Powell-Brett","year":"2024","unstructured":"Powell-Brett S, Halle-Smith JM, Hall LA, Hodson J, Phillips ME, Roberts KJ (2024) Comprehensive, long-term evaluation of pancreatic exocrine insufficiency after pancreatoduodenectomy. Pancreatology 24:298\u2013305. https:\/\/doi.org\/10.1016\/j.pan.2023.11.016","journal-title":"Pancreatology"},{"key":"4118_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.846276","volume":"9","author":"H Xing","year":"2022","unstructured":"Xing H, Tan B, Yang C, Zhang M (2022) Incidence trend and competing risk analysis of patients with intrahepatic cholangiocarcinoma: a population-based study. Front Med (Lausanne) 9:846276. https:\/\/doi.org\/10.3389\/fmed.2022.846276","journal-title":"Front Med (Lausanne)"},{"key":"4118_CR32","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/s0140-6736(21)00153-7","volume":"397","author":"JW Valle","year":"2021","unstructured":"Valle JW, Kelley RK, Nervi B, Oh DY, Zhu AX (2021) Biliary tract cancer. Lancet 397:428\u2013444. https:\/\/doi.org\/10.1016\/s0140-6736(21)00153-7","journal-title":"Lancet"},{"key":"4118_CR33","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jhep.2020.03.007","volume":"73","author":"A Lamarca","year":"2020","unstructured":"Lamarca A, Barriuso J, McNamara MG, Valle JW (2020) Molecular targeted therapies: ready for \u201cprime time\u201d in biliary tract cancer. J Hepatol 73:170\u2013185. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.007","journal-title":"J Hepatol"},{"key":"4118_CR34","doi-asserted-by":"publisher","first-page":"829407","DOI":"10.3389\/fonc.2022.829407","volume":"12","author":"H Li","year":"2022","unstructured":"Li H, Liu R, Qiu H et al (2022) Tumor Burden Score Stratifies Prognosis of Patients With Intrahepatic Cholangiocarcinoma After Hepatic Resection: A Retrospective, Multi-Institutional Study. Front Oncol 12:829407. https:\/\/doi.org\/10.3389\/fonc.2022.829407","journal-title":"Front Oncol"},{"key":"4118_CR35","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1097\/mog.0000000000000611","volume":"36","author":"C Louis","year":"2020","unstructured":"Louis C, Papoutsoglou P, Coulouarn C (2020) Molecular classification of cholangiocarcinoma. Curr Opin Gastroenterol 36:57\u201362. https:\/\/doi.org\/10.1097\/mog.0000000000000611","journal-title":"Curr Opin Gastroenterol"},{"key":"4118_CR36","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/s1470-2045(18)30915-x","volume":"20","author":"JN Primrose","year":"2019","unstructured":"Primrose JN, Fox RP, Palmer DH et al (2019) Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol 20:663\u2013673. https:\/\/doi.org\/10.1016\/s1470-2045(18)30915-x","journal-title":"Lancet Oncol"},{"key":"4118_CR37","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.hpb.2023.11.007","volume":"26","author":"M Yeow","year":"2024","unstructured":"Yeow M, Fong KY, Zhao JJ et al (2024) Value of lymph node dissection in intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. HPB (Oxford) 26:161\u2013170. https:\/\/doi.org\/10.1016\/j.hpb.2023.11.007","journal-title":"HPB (Oxford)"},{"key":"4118_CR38","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1097\/meg.0000000000002856","volume":"36","author":"R Zhang","year":"2024","unstructured":"Zhang R, Tan Y, Liu M, Wang L (2024) Lymph node metastasis of intrahepatic cholangiocarcinoma: the present and prospect of detection and dissection. Eur J Gastroenterol Hepatol 36:1359\u20131369. https:\/\/doi.org\/10.1097\/meg.0000000000002856","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4118_CR39","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1007\/s11605-020-04622-6","volume":"25","author":"SH Kim","year":"2021","unstructured":"Kim SH, Han DH, Choi GH, Choi JS, Kim KS (2021) Recommended Minimal Number of Harvested Lymph Nodes for Intrahepatic Cholangiocarcinoma. J Gastrointest Surg 25:1164\u20131171. https:\/\/doi.org\/10.1007\/s11605-020-04622-6","journal-title":"J Gastrointest Surg"},{"key":"4118_CR40","doi-asserted-by":"publisher","DOI":"10.1200\/po-25-00402","volume":"9","author":"P Chandra","year":"2025","unstructured":"Chandra P, Song Y, Drill E et al (2025) Intrahepatic cholangiocarcinoma: recurrence patterns, genomics, and survival. JCO Precis Oncol 9:e2500402. https:\/\/doi.org\/10.1200\/po-25-00402","journal-title":"JCO Precis Oncol"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00423-026-04118-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-026-04118-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-026-04118-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:45:40Z","timestamp":1789425940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00423-026-04118-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4118"],"URL":"https:\/\/doi.org\/10.1007\/s00423-026-04118-y","relation":{},"ISSN":["1435-2451"],"issn-type":[{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"6 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"234"}}